Remove 2025 Remove Contracts Remove Licensing Remove Registration
article thumbnail

Recent Biosimilar Commercialization Developments

LexBlog IP

has announced an exclusive licensing agreement with Tonghua Dongbao Pharmaceuticals Co., According to the press release, the first molecules subject to the agreement are expected to launch as early as 2025. Insulin Biosimilars: Meitheal Pharmaceuticals, Inc. Anti-Tumor Biosimilars: Chime Biologics Ltd.,

article thumbnail

ERA IP-focused events and courses return with 25% discount for IPKat readers

The IPKat

Over the next few months, the following will take place and IPKat readers will have an opportunity to enroll with a 25% discount in the registration fees: Summer Course on European Intellectual Property Law Trier, 1-5 July 2024 This course will provide a thorough introduction to European intellectual property law.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What Business Owners Need to Know About the Corporate Transparency Act

LexBlog IP

Each Reporting Company is required to report: Entity name (and any alternative trade or d/b/a name); Business street address; Jurisdiction of formation and, for foreign entities, the State or Tribal jurisdiction of registration; and A unique identification number (such as TIN, EIN, LEI, etc.). What is Considered an Ownership Interest?

article thumbnail

IP and Cannabis: The Current Landscape

Fish & Richardson Trademark & Copyright Thoughts

billion by 2025. [ii] Federal trademark registration is the strongest form of protection, as it is nationwide in scope and gives potential infringers constructive notice by virtue of being published in the Trademark Register. billion, with an expected increase to $29.7 Patent Prosecution.

IP 52